Menopause joint pain has been one of the hardest parts of my last 15 years, and for years no one would connect the two. The pain was in my shoulders, my hips and my knees, and it was dismissed again and again.
On October 18, World Menopause Day will put this front and centre. The International Menopause Society has chosen chronic pain at midlife as its 2026 theme, and its new White Paper puts in writing what I spent years asking about.
So, this one is personal.
Two Frozen Shoulders and No Explanation
I have had two frozen shoulders, and both needed surgery. One lasted three years before surgery.
I have given birth. I have had other surgeries and other illnesses. Nothing compares to that pain.
It was excruciating and debilitating, and it contributed to severe sleep loss. It affected every part of my life and what I could take part in.
I tried it all, including several types of physiotherapy and cortisone shots. Every time I saw an orthopedic surgeon, I was dismissed and told to wait it out.
“Idiopathic” Is Not an Answer
The word I kept hearing was idiopathic, the medical term for no known cause. That made no sense to me.
I had no injury. I also knew that frozen shoulder is most common between the ages of 40 and 60 and occurs in women more often than men, which is how the American Academy of Orthopedic Surgeons describes it today. A condition that shows up in women during the menopause years, with no injury behind it, had to have something to do with hormones.
I asked. Each time I raised hormones, I was looked at as if I had thorns growing out of my head.
I was not the only one asking. In 2022, Duke University orthopedic surgeon Dr. Jocelyn Wittstein said it plainly:
“A disease that has such a strong predilection for women is unlikely to be truly idiopathic.”
Recently I went back to one of my shoulder surgeons and asked whether he now believes low estrogen played a part. He shrugged and allowed that there might be some contribution. That was as far as he would go.
What the New White Paper Says
The 2026 IMS White Paper, Chronic Pain at Midlife, was published in the journal Climacteric by ten international experts. Five of them work in the Toronto area, at the University of Toronto, Women’s College Hospital, Mount Sinai Hospital and the Pain & Wellness Centre in Maple, Ontario.
Their conclusion is direct. Chronic pain in midlife women is “often under-recognized, underdiagnosed and inadequately treated.”
The numbers show how many women that describes.
| What the research found | Source |
| About half of midlife women experience chronic pain. | IMS White Paper, Climacteric, 2026 |
| About 71 percent of perimenopausal women have muscle and joint pain. | Lu and colleagues, Neural Plasticity, 2020, a review of 16 studies |
| Women make up 62 to 68 percent of patients in the Canadian pain clinics studied. | IMS White Paper, citing two Canadian pain clinic studies |
| One in four Canadians aged 15 or older lives with chronic pain, at a cost of $38.3 to $40.4 billion in 2019. | Canadian Pain Task Force, October 2020 |
The paper also names what happened to my shoulders. It lists adhesive capsulitis, the clinical name for frozen shoulder, among a group of muscle, joint and bone changes potentially related to low estrogen. A team led by orthopedic surgeon Dr. Vonda Wright named that group the musculoskeletal syndrome of menopause in 2024.
It notes, too, that shoulder pain around menopause is so frequently reported in Chinese populations that Traditional Chinese Medicine has a name for it: the 50-year shoulder.
Why Estrogen and Pain are Connected
Estrogen does far more than regulate periods. According to the White Paper, it influences how the body processes pain, as well as sleep, mood, muscle mass, connective tissue, and inflammation.
When estrogen falls in perimenopause and after menopause, pain in the muscles and joints may increase, and so may the way the nervous system amplifies it. Sleep adds to the problem, because poor sleep increases pain sensitivity and chronic pain disrupts sleep in return.
What the Frozen Shoulder Research Shows
The research on frozen shoulder and hormones is newer, and it is moving quickly. Three studies have now compared women who use hormone therapy with women who do not, and all three point in the same direction.
| Study | What it found | What to keep in mind |
| Shah and colleagues, 2026. US health records, 299,723 matched women aged 40 to 60 in each group. | Frozen shoulder developed in 0.95 percent of women not on hormone therapy and 0.75 percent of women on it. The difference was statistically significant. | Conference abstract. It shows an association, not a cause. |
| Wittstein and colleagues, 2026. Survey of 13,946 postmenopausal women aged 45 to 65. | Frozen shoulder occurred in 3.8 percent of women after they started hormone therapy and 25.0 percent of women not on it. Among women who started hormone therapy after a diagnosis, 58.2 percent felt their symptoms improved. | Conference abstract. Self-reported answers from women recruited through physicians’ social media, so not a representative sample. |
| Reinke, Wittstein and colleagues, Climacteric, 2026. Duke University pilot study of 1,952 postmenopausal women. | Frozen shoulder was diagnosed in 7.65 percent of women not on hormone therapy and 3.95 percent of women on it. The difference was not statistically significant. | Only 152 of the women were on hormone therapy. The authors called for larger studies. |
In the laboratory, a 2025 study in The Journal of Steroid Biochemistry and Molecular Biology found that estrogen had antifibrotic effects in frozen shoulder, improving shoulder mobility and reducing fibrous tissue in the capsule around the joint. At the University of California, San Francisco, a randomized trial that began in January 2026 is testing hormone therapy alongside standard treatment in 60 women with frozen shoulder.
It is also being said in public. In January 2026, Dr. Mary Claire Haver devoted an episode of her podcast to frozen shoulder and menopause with Dr. Wittstein as her guest, and in July TIME reported on the same research.
None of this proves that menopause causes frozen shoulder. As Dr. Wittstein told HealthCentral in 2026:
“There’s not a study that clearly proves menopause is the cause of frozen shoulder, but there is evidence at the level of association.”
That is a long way from a shrug. The question I was told was ridiculous is now the subject of large studies and a clinical trial. It is about time.
The Connection to Bone Loss and Fractures
Joints are only part of this story. The same White Paper lists lower bone density and a higher risk of fracture alongside joint pain and frozen shoulder, all potentially related to low estrogen.
This is personal too. My mother never had any bone health prevention. She now has five spinal fractures that happened with no injury at all.
The bone crumbled and burst. She has suffered incredibly.
She is far from alone. Osteoporosis Canada reports that women lose bone at a rate of 2 to 3 percent a year as they approach menopause, and that at least one in three women will have an osteoporotic fracture in her lifetime. Fewer than 20 percent of fracture patients in Canada are diagnosed or adequately treated for osteoporosis.
These fractures do not need a fall. The American Academy of Orthopedic Surgeons notes that people with osteoporosis can break a bone during everyday movements such as reaching, twisting, coughing, or sneezing.
The same guideline suggests menopausal hormone therapy as an option for women under 60, or within 10 years of menopause, who are starting medication and want relief from substantial menopausal symptoms.
My mother did not get that prevention. I want every woman reading this to ask for it.
Why It Gets Missed
The White Paper describes pain being managed in isolation across gynecology, psychiatry, neurology, rheumatology and pain medicine. Its authors write that menopausal symptoms can worsen existing pain or contribute to new pain yet are “often misattributed to aging or comorbid diseases.”
That matches my experience. I do not believe my surgeons were indifferent. They did not have the training or the language to connect a shoulder to a hormone.
The paper is clear about what should happen instead. It calls validation of a patient’s pain a therapeutic intervention in its own right:
“Being believed, heard and understood is often the first step toward recovery.”
What It Looks Like at Work
Pain does not stay home. When the frozen shoulder was in my right arm, I could barely move it to use a mouse or write.
I had a desk job, so the impact was smaller than it could have been. If I had been a nurse or a factory worker, I would have had to go on sick leave.
I could not find Canadian workplace data on joint pain specifically, so the closest figures come from the United Kingdom. In a 2023 CIPD survey of 2,185 employed women aged 40 to 60, 64 percent of those with menopause symptoms reported muscle and joint problems. Among the women whose symptoms had a negative effect at work, 46 percent said they were less physically able to carry out their work tasks and 14 percent had taken time off as sick leave.
In Canada, the Menopause Foundation of Canada estimates that unmanaged menopause symptoms cost the economy $3.5 billion a year.
The White Paper calls for a public conversation that acknowledges “the impact of chronic pain on education, family, career and broader women’s life-course trajectories.” Workplaces are part of that conversation.
What Helps
The White Paper is careful here, and I will be too. Its authors found the strongest evidence for regular physical activity, resistance training, weight management, sleep, stress management and active rehabilitation, and limited evidence for many supplements.
On hormone therapy for general muscle and joint pain, the evidence is mixed. A recent analysis of 57 studies found no significant overall effect in randomized trials, and the White Paper says the evidence does not support hormone therapy as a painkiller once chronic pain is established. That analysis looked at general muscle and joint pain, not frozen shoulder specifically.
The White Paper’s authors also say a cautious, individualized trial of hormone therapy may be considered for women whose pain is new with menopause, after a discussion of the limited evidence and the risks.
I have written about lifestyle habits and non-hormonal options in earlier posts. What I want to add today is simpler.
If your joints hurt and you are in your 40s or 50s, ask whether menopause could be part of it, and keep asking. And keep moving. We need to build muscle mass, keep our joints moving, and work on mobility and flexibility if we want to age stronger.
What Employers Can Do
Start by putting pain on the list. If your menopause education covers hot flashes and brain fog and stops there, it is missing a symptom that affects about seven in ten women in perimenopause.
Then look at the work itself, starting with flexibility. In the CIPD survey, planned flexible working was the adjustment women most often rated as helpful, at 48 percent. UK government guidance for employers, published in 2026, lists flexible working hours and ergonomic office furniture, and The Menopause Society’s employer guide recommends time off for health care appointments.
For an arm or shoulder that will not move, the Job Accommodation Network lists speech recognition software, alternative mice, forearm supports and adjustable workstations. That is the list for a right arm that cannot use a mouse or hold a pen. The UK Faculty of Occupational Medicine adds space to move for women in sedentary roles and somewhere to sit when the work means constant standing.
Physical jobs need a different list. A workplace adjustments guide hosted by Scotland’s National Wellbeing Hub suggests reviewing manual handling tasks, offering lighter duties or lifting equipment, and considering temporary changes to duties for staff with muscle, bone and joint pain.
Then train managers. The global consensus recommendations from the European Menopause and Andropause Society call for training managers and supervisors to have sensitive conversations at work.
A woman who is believed will ask for what she needs. A woman who is dismissed learns to stop asking.
Why I Am Telling You This
I knew my pain was connected to my hormones long before anyone would say so. Now the International Menopause Society has put it in writing.
I am telling this story so that the next woman who asks her doctor or her manager gets a better answer than a shrug. I am telling my mother’s story so that bone health becomes part of the conversation before a fracture, not after.
World Menopause Day is October 18. Let’s use it to talk about pain.
—
I am not a doctor. Always talk to your own doctor before starting, stopping, or changing any medication.
Aimee Debow is the Founder of Menovate and a certified Menopause Coach. She appeared as a witness before the House of Commons Standing Committee on the Status of Women in June 2026. Menovate helps Canadian organizations build menopause-supportive workplaces through corporate talks, e-learning, and HR advisory services. Learn more at menovate.ca